Retinitis Pigmentosa (RP) functions as a degenerative disease that attacks the retina while causing vision deterioration until total blindness emerges in several patients. The widespread rare inherited eye disorder known as RP disrupts major life activities of those living with this condition. The traditional available treatment for RP involved symptom control and disease progression delay
The loss of vision causes severe life-altering problems. The effect of vision loss becomes severe because of three main groups of causes including age-related macular degeneration with retinal diseases and genetic conditions. The field of medical science provides new possibilities for treating eye vision loss that used to be managed through either symptom control or
Rod and cone dystrophy forms a collection of inherited retinal disorders that attack the rod and cone cells inside the retina. These special light-sensitive cells receive signals from the brain by picking up light energy. The eyesight loss from this condition becomes more severe until patients lose all light perception. Stem cell therapy provides new
The hereditary eye diseases which constitute retinal dystrophy reduce retina health through sustained degeneration that creates vision loss and may result in blindness. These genetic conditions produce the damage that current therapies struggle to counter or repair. The advancements in medical science through stem cell therapy bring new hope as a potential therapeutic solution to